Garry E. Menzel - 05 Jul 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC.

Role
President & CEO, Director
Signature
Margaret Siegel as Attorney-In-Fact
Issuer symbol
N/A
Transactions as of
05 Jul 2022
Net transactions value
$0
Form type
4
Filing time
26 Aug 2022, 16:30:58 UTC
Previous filing
13 Jun 2022
Next filing
18 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRR Common Stock Gift $0 -84,527 -100% $0.000000* 0 05 Jul 2022 See Footnote F1
transaction TCRR Common Stock Gift $0 +84,527 $0.000000 84,527 05 Jul 2022 See Footnote F1
transaction TCRR Common Stock Gift $0 -48,202 -27% $0.000000 132,730 05 Jul 2022 Direct F2
transaction TCRR Common Stock Gift $0 +48,202 +57% $0.000000 132,729 05 Jul 2022 See Footnote F2
transaction TCRR Common Stock Gift $0 -132,730 -100% $0.000000* 0 05 Jul 2022 Direct F3
transaction TCRR Common Stock Gift $0 +132,730 $0.000000 132,730 05 Jul 2022 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the disposition for no consideration on July 5, 2022 of 84,527 shares of common stock held by the reporting person, as Trustee of the Garry E. Menzel and Mary E. Henshall Family Trust, under instrument of trust dated July 29, 2010, to the Garry E. Menzel Revocable Trust of 2022, under Indenture of Trust dated April 45, 2022 (the "Menzel Trust"). The reporting person is the trustee of the Menzel Trust and may be deemed to beneficially own these securities. The reporting person and members of his immediate family are the sole beneficiaries of the Menzel Trust.
F2 The reporting person is voluntarily reporting the disposition for no consideration on July 5, 2022 of 48,202 shares of common stock held by the reporting person to the Menzel Trust.
F3 The reporting person is voluntarily reporting the disposition for no consideration on July 5, 2022 of 132,730 shares of common stock held by the reporting person to the Mary E. Henshall Revocable Trust of 2022, under Indenture of Trust dated April 5, 2022 (the "Henshall Trust"). The reporting person's spouse is the trustee of the Henshall Trust, and as such the reporting person may be deemed to beneficially own these securities. The reporting person and members of his immediate family are the sole beneficiaries of the Henshall Trust.